Improved detection of replication-competent retrovirus

Journal of Virological Methods

Volumn 60, Issue 2, 1996, Pages 171-178

  Forestell, Sean P ^a   Dando, Jonathan S ^a   Böhnlein, Ernst ^a   Rigg, Richard J ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SUPERNATANT; VIRUS DETECTION; VIRUS REPLICATION;

ANIMALIA; MUS DUNNI; UNIDENTIFIED RETROVIRUS;

EID: 0030200513     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-0934(96)02052-6     Document Type: Article

References (22)

1. Bagnis, C., Cosset, F.L., Samarut, J. and Moscovici, C. (1993) Leukemogenicity of v-myb transformed monoblast cells can be modulated by normal bone marrow environment. Oncogene 8, 737-743.
2. Bahnson, A.B., Dunigan, J.T., Baysal, B.E., Mohney, T., Atchison, R.W., Nimgaonkar, M.T., Ball, E.D. and Barranger, J.A. (1995) Centrifugal enhancement of retroviral-mediated gene transfer. J. Virol. Methods 54, 131-143.
3. Corbley, M.J., Cherington, V., Feig, L.A., Cooper, G.M. and Roberts, T.M. (1994) Rapid regeneration of virus from cells infected with a retro viral vector. BioTechniques 17, 1102-1109.
4. Cornetta, K., Nguyen, N., Morgan, R.A., Muenchau, D.D., Hartley, J.W., Blaese, R.M. and Anderson, W.F. (1993) Infection of human cells with murine amphotropic replication-competent retroviruses. Hum. Gene Ther. 4, 579-588.
5. Cosset, F.L., Girod, A., Flamant, F., Drynda, A., Ronforth, C., Valsesia, S., Molina, R.M., Faure, C., Nigon, V.M. and Verdier, G. (1993) Use of helper cells with two host ranges to generate high-titer retro viral vectors. Virology 193, 385-395.
6. Danos, O. (1991) Viral vectors for gene expression. In: M. Collins (Ed.), Methods in Molecular Biology, Vol. 8: Practical Molecular Virology. Humana Press, Clifton, New Jersey, pp. 17-27.
7. Danos, O. and Mulligan, R. (1988) Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
8. Escaich, S., Kalfoglou C., Plavec I., Kaushal S., Mosca J.D. and Böhnlein E. (1995). RevM10 mediated inhibition of HIV-1 replication in chronically infected T-cells. Hum Gene Ther. 6, 625-634.
9. Forestell, S.P., Böhnlein, E. and Rigg, R.J. (1995) Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 2, 723-730.
10. Haapala, D.K., Robey, W.G., Oroszlan, S.D. and Tsai, W.P. (1985) Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J. Virol. 53, 827-833.
11. Kotani, H., Newton, P.B., Zhang, S, Chiang, Y.L., Otto, E., Weaver, L., Blaese, R.M., Anderson, W.F. and McGarrity, G.J. (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
12. Lander, M.R. and Chattopadhyay, S.K. (1984) A M. dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J. Virol. 52, 695-698.
13. Miller, A.D. (1990) Retroviral packaging cells. Hum. Gene Ther. 1, 5-14.
14. Miller, A.D. and Rosman, G.J. (1989) Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
15. Morling, F.J. and Russell, S.J. (1995) Enhanced transduction efficiencies of retroviral vectors coprecipitated with calcium phosphate. Gene Ther. 2, 504-508.
16. Muenchau, D.D., Freeman, S.M., Cornetta, K., Zwiebel, J.A. and Anderson, W.F. (1990) Analysis of retroviral packaging lines for generation of replication-competent retrovirus. Virology 176, 262-265.
17. Ott, D., Friedrich, R. and Rein, A. (1990) Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-forming viruses. J. Virol. 64, 757-766.
18. Otto, E., Jones-Trower, A., Vanin, E.F., Stambaugh, K., Mueller, S.N., Anderson, W.F. and McGarrity, G.J. (1994) Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum. Gene Ther. 5, 567-575.
19. Printz, M., Reynolds, J., Mento, S.J., Jolly, D., Kowal, K. and Sajjadi, N. (1995) Recombinant retroviral vector interferes with the detection of amphotropic replication-competent retrovirus in standard culture assays. Gene Ther. 2, 143-150.
20. Rigg, R.J., Chen, J., Dando, J.S., Forestell, S.P., Plavec, I. and Böhnlein, E. (1996) A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Virology 218, 290-295.
21. US Food and Drug Administration, Center for Biologics Evaluation and Research, Vaccines and Related Products Advisory Committee, transcript of meeting, 25 October 1993. Center for Biologics, FDA, Bethesda, MD 20205, USA.
22. Vanin, E.F., Kaloss, M., Broscius, C. and Nienhuis, A.W. (1994) Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 63, 4241-4250.